Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness).
Multiple sclerosis in 2015: Managing the complexity of multiple sclerosis.
The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis.
Impact of cost sharing on specialty drug utilization and outcomes: a review of the evidence and future directions.
The development of myelin repair agents for treatment of multiple sclerosis: Progress and challenges.
New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review.
Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis.
Role of STIM-dependent Ca(2+) Influx in Regulatory B Cells.
Reliability of classifying multiple sclerosis disease activity using magnetic resonance imaging in a multiple sclerosis clinic.
Reliability of Longitudinal Brain Volume Loss Measurements between 2 Sites in Patients with Multiple Sclerosis: Comparison of 7 Quantification Techniques.
Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis.
The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo.
The Effect of a Creative Art Program on Self-Esteem, Hope, Perceived Social Support, and Self-Efficacy in Individuals With Multiple Sclerosis: A Pilot Study.
Analysis of polymorphisms in RIG-I-like receptor genes in German multiple sclerosis patients.
Free radicals: properties, sources, targets, and their implication in various diseases.
The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis.
Activity-dependent regulation of excitable axonal domains.
Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
Nonallergic comorbidities of atopic eczema: an overview of systematic reviews.
Antibody index test may aid PML diagnosis on natalizumab
[Cognitive deficits and dementia in patients with multiple sclerosis: status quo and open questions].
Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.
Characterization of the first K(+) channel blockers from the venom of the Moroccan scorpion Buthus occitanus Paris.
[NMO Spectrum Disorders and Anti AQP4 Antibody].
Evidence for a multiple sclerosis epidemic?

Pages